Skip To Main Content
Xiaoying Ding on Muck Rack

Xiaoying Ding

As seen in: Wiley Online Library, Frontiers, MDPI, Science Magazine, Dove Medical Press, Optica
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiaoying

Contact Xiaoying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Overweight/obesity accelerates proteinuria progression in type 2 diabetes post-COVID-19: a comparison with a pre-pandemic uninfected cohort

|
By Jiajun Wu, Liping Gu, Qin Zhen, Jiaying Yang, Yizhe Wang, Yongcheng Zhang, Yizhen Chen, Fang Liu, Xiaoying Ding, Yufan Wang
| Frontiers
Abstract Aims: To assess whether overweight/obesity accelerates proteinuria progression in patients with type 2 diabetes mellitus (T2DM) after coronavirus disease 2019 (COVID-19) infection. Methods: This retrospective study included 688 patients with T2DM confirmed to have COVID-19 infection and 502 pre-pandemic uninfected patients with T2DM for comparative analysis.
Open in Who Shared Issue with article?

COVID-19 associated CKM syndrome progression in diabetic patients is linked to pancreatic beta cell dysfunction, rather than RASi use: a retrospective cohort study

|
By Yongcheng Zhang, Ziqi Wang, Yizhe Wang, Ran Bao, Liping Gu, Yuhang Ma, Xiaoying Ding
| Frontiers
Abstract Background and aims: SARS-CoV-2 primarily has tissue tropism for the respiratory epithelium; however, it may cause multiple organ dysfunction due to the widespread expression of its entry receptor, ACE2. Specifically, SARS-CoV-2 may enter pancreatic β-cells by exploiting ACE2, disrupting cellular and hormonal activity, and thereby worsening Cardiovascular-Kidney-Metabolic (CKM) syndrome prognosis in diabetic patients.
Open in Who Shared Issue with article?

Editorial: Novel strategies for the clinical management of cardiovascular-kidney-metabolic syndrome

|
By Yun Shen, Junfeng Han, Xiaoying Ding
| Frontiers
The cardiovascular–kidney–metabolic (CKM) syndrome framework formalizes what clinicians have long observed: obesity, dysglycaemia, chronic kidney disease (CKD), and cardiovascular disease (CVD) are not parallel epidemics but intertwined disorders connected by shared pathobiology (insulin resistance, glucolipotoxicity, endothelial dysfunction, inflammation, oxidative stress, and maladaptive neurohormonal activation) that accelerate organ damage and premature death.
Open in Who Shared Issue with article?
See all 14 articles